Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Anal Bioanal Chem. 2011 Sep;401(5):1585-91. doi: 10.1007/s00216-011-5225-7. Epub 2011 Jul 13.
Ultrafiltration provides a generic method to discover ligands for protein drug targets with millimolar to micromolar K(d), the typical range of fragment-based drug discovery. This method was tailored to a 96-well format, and cocktails of fragment-sized molecules, with molecular masses between 150 and 300 Da, were screened against medical structural genomics target proteins. The validity of the method was confirmed through competitive binding assays in the presence of ligands known to bind the target proteins.
超滤提供了一种通用的方法,用于发现具有毫摩尔至微摩尔 K(d)(片段药物发现的典型范围)的蛋白质药物靶标的配体。该方法针对 96 孔格式进行了定制,并筛选了分子量在 150 至 300 道尔顿之间的片段大小的分子混合物,以针对医学结构基因组学靶蛋白。该方法通过在存在已知与靶蛋白结合的配体的情况下进行竞争结合测定来验证其有效性。